Drugs / Recombinant Hepatitis B new Bulk vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05482282 | Dec 2025 → Dec 2026 | hepatitis B virus infection | PT Bio Farma | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant Hepatitis B new Bulk vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05482282 ↗ |
| Modality | Vaccine | “Recombinant Hepatitis B new Bulk vaccine” NCT05482282 ↗ |
| Route | Intramuscular | “injected intramuscularly” NCT05482282 ↗ |